For example, the mitogen-activated protein kinase (MAPK) pathway, a downstream pathway of KRAS, plays a central role in the initiation and progression of cancers driven by RAS or RAF mutations, including PDAC, colorectal cancer, lung cancer, and melanoma [118]. Here, KRAS is linked to lung carcinoma.